-
Product Insights
Innovations in IM Nails – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in IM Nails - Global Pipeline Summary" provides comprehensive information about the IM Nails pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The IM Nails report provides key information and data related to: Extensive coverage of the IM Nails under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Autoimmune Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Autoimmune Disorders Drug Details: IM-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Myasthenia Gravis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Myasthenia Gravis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Myasthenia Gravis Drug Details: IM-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-19 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-19 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-19 in Mantle Cell Lymphoma Drug Details: IM-19 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Paroxysmal Nocturnal Hemoglobinuria Drug Details: IM-101 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Age Related Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Age Related Macular Degeneration report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Age Related Macular Degeneration Drug Details: IM-101...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-19 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-19 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-19 in Diffuse Large B-Cell Lymphoma Drug Details: IM-19...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-19 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-19 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-19 in Primary Mediastinal B-Cell Lymphoma Drug Details: IM-19...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMS-001 in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMS-001 in Relapsing Remitting Multiple Sclerosis (RRMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-19 in B-Cell Chronic Lymphocytic Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-19 in B-Cell Chronic Lymphocytic Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-19 in B-Cell Chronic Lymphocytic Leukemia Drug Details: IM-19...